Antibody Contract Manufacturing Market : Industry Trends and Global Forecasts - Distribution by Type of Antibody Manufactured, Type of Expression System Used, Scale of Operation, and Geographical Regions
As per Roots Analysis, the global antibody contract manufacturing market is estimated to grow from USD 16.6 billion in the current year to USD 47 billion by 2035, at a CAGR of 10% during the forecast period, till 2035.
The market sizing and opportunity analysis has been segmented across the following parameters:
Type of Antibody Manufactured
Monoclonal
Bispecific
Type of Expression System Used
Mammalian
Microbial
Scale of Operation
Clinical
Commercial
Geographical Regions
North America
Europe
Asia
Latin America
Middle East and North Africa
ANTIBODY CONTRACT MANUFACTURING MARKET: GROWTH AND TRENDS
In recent years, contract manufacturers have become an integral part of the overall biopharmaceutical market. This trend is also gaining popularity within the antibody manufacturing market, as developers are increasingly outsourcing their antibody manufacturing requirements to contract service providers. This can be attributed to the fact that employing such third-party service providers offers various advantages, such as a reduction in overall production cost and access to the specialized expertise of these contract manufacturers. In fact, antibody manufacturing companies engaged in this domain are actively collaborating with other players and expanding their existing capabilities and capacities in order to cater to the overall demand for therapeutic antibodies.
Since the approval of Orthoclone OKT3(R) in 1986, monoclonal antibodies have become an important part of modern healthcare practices. In fact, several experts consider monoclonal antibodies to be the backbone of the biopharmaceutical industry. Owing to their high specificity and the favorable safety profile, antibody-based interventions presently constitute the largest class of biologics contract manufacturing market. This trend is likely to remain the same in the near future as advanced variants of antibodies, such as bispecific antibodies and antibody fragments-based products, are steadily gaining traction. Further, owing to challenges associated with the development and production of biologics, such as advanced supply chain requirements, outsourcing antibody production operation is expected to witness significant growth.
The report delves into the current state of the antibody contract manufacturing market and identifies potential growth opportunities within industry. Some key findings from the report include:
Presently, over 125 contract manufacturers claim to offer services for antibody manufacturing across the globe; 74% of the service providers manufacture monoclonal antibodies at commercial scale.
The current market landscape is fragmented, featuring the presence of both large players and new entrants; most of these are mid-sized players (43%) based in North America.
In pursuit of gaining a competitive edge in this field, stakeholders are actively upgrading their existing capabilities and adding new competencies in order to enhance their respective portfolios.
The ongoing efforts to improve capabilities and upgrade facilities have led to the establishment of industry benchmarks, which serve as a standard for new product development initiatives.
The growing interest of stakeholders in this domain is evident from the rise in partnership activity; most of the partnerships signed were focused on antibody manufacturing.
In order to enhance core competencies related to this field of research, CMOs are actively investing in upgrading existing infrastructure and expanding their respective manufacturing capacities.
The global installed antibody contract manufacturing capacity is spread across various regions; over 55% of this capacity is available in manufacturing facilities based in North America.
Given that there are several antibody-based drug / therapy candidates being evaluated across various stages of development, the demand for such products is anticipated to rise significantly over the next decade.
The antibody manufacturing market is likely to grow at a CAGR of 10%, till 2035; presently, majority of the market share is occupied by North America, followed by Europe.
Monoclonal Antibodies Occupy the Largest Share of the Global Antibody Contract Manufacturing Market
Based on the type of antibody manufactured, the market is segmented into monoclonal and bispecific antibody. At present, the monoclonal antibody segment holds the maximum share of the global antibody contract manufacturing market. However, players are now increasingly focusing on the development of bispecific antibodies for therapeutic use.
By Type of Expression System Used, Microbial Expression System is the Fastest Growing Segment of the Global Antibody Contract Manufacturing Market
Based on the type of expression system used, the market is segmented into mammalian and microbial expression systems. Currently, the mammalian expression system segment captures the highest proportion of the global antibody contract manufacturing market owing to the fact that mammalian expression systems allow antibodies to produce higher biological activity and binding affinity.
By Scale of Operation, Commercial Scale Segment Occupies the Largest Share of the Global Antibody Contract Manufacturing Market
Based on the scale of operation, the market is segmented into clinical and commercial scale. At present, the commercial segment holds the maximum share of the global antibody contract manufacturing market owing to the increasing demand for commercial production of antibodies.
North America Accounts for the Largest Share of the Market
Based on key geographical regions, the market is segmented into North America, Europe, Asia, Latin America and Middle East and North Africa. Currently, North America dominates the antibody contract manufacturing market and accounts for the largest revenue share. Additionally, the market in Asia is likely to grow at a higher CAGR in the coming future.
Example Players in the Antibody Contract Manufacturing Market
AGC Biologics
Aldevron
Emergent BioSolutions
Eurofins CDMO
FUJIFILM Diosynth Biotechnologies
KBI Biopharma
Lonza
Nitto Avecia Pharma Services
Novasep
Pierre Fabre
Samsung BioLogics
Synthon
Thermo Fisher Scientific
ANTIBODY CONTRACT MANUFACTURING MARKET: RESEARCH COVERAGE
Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global antibody contract manufacturing market, focusing on key market segments, including [A] type of antibody manufactured, [B] type of expression system used, [C] scale of operation and [D] geographical regions.
Market Landscape: A comprehensive evaluation of the companies engaged in antibody contract manufacturing market, based on several relevant parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] location of manufacturing facilities, [E] scale of operation, [F] type of antibody, [G] type of expression systems used, [H] fill / finish operations and [I] affiliations to regulatory agencies.
Company Competitiveness Analysis: A comprehensive competitive analysis of antibody contract manufacturers, examining factors, such as [A] company strength and [B] portfolio strength and [C] portfolio diversity.
Company Profiles: In-depth profiles of key service providers engaged in the antibody contract manufacturing market, focusing on [A] overview of the company, [B] financial information (if available), [C] service portfolio, and [D] recent developments and an informed future outlook.
Case Study: A detailed comparison of the key characteristics of large and small molecule drugs, along with information on the steps and challenges involved in their respective manufacturing processes.
Benchmark Analysis: A detailed analysis of the key focus areas of small, mid-sized, large and very large companies by comparing their existing capabilities within and beyond their respective peer groups.
Capacity Analysis: An insightful analysis of the overall, installed capacity for manufacturing antibodies, based on various parameters, such as [A] company size and [B] key geographical regions.
Demand Analysis: An in-depth analysis of the annual commercial and clinical demand for antibodies, based on various relevant parameters, such as [A] target patient population, [B] dosing frequency and [C] dose strength.
SWOT Analysis: An analysis of industry affiliated trends, opportunities and challenges, which are likely to impact the evolution of antibody contract manufacturing market; it includes a Harvey ball analysis, assessing the relative impact of each SWOT parameter on industry dynamics.
KEY QUESTIONS ANSWERED IN THIS REPORT
How many companies are currently engaged in this market?
Which are the leading companies in this market?
What factors are likely to influence the evolution of this market?
What is the current and future market size?
What is the CAGR of this market?
How is the current and future market opportunity likely to be distributed across key market segments?
REASONS TO BUY THIS REPORT
The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
ADDITIONAL BENEFITS
Complimentary PPT Insights Packs
Complimentary Excel Data Packs for all Analytical Modules in the Report
15% Free Content Customization
Detailed Report Walkthrough Session with Research Team
Free Updated report if the report is 6-12 months old or older
TABLE OF CONTENTS
1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Future Estimates
3.2.2. Currency Coverage and Foreign Exchange Rate
3.2.2.1. Major Currencies Affecting the Market
3.2.2.2. Factors Affecting Currency Fluctuations and Foreign Exchange Rates
3.2.2.3. Impact of Foreign Exchange Rate Volatility on the Market
3.2.2.4. Strategies for Mitigating Foreign Exchange Risks
3.2.3. Trade Policies
3.2.3.1. Impact of Trade Barriers on the Market
3.2.3.2. Strategies for Mitigating the Risks associated with Trade Barriers
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution
4. EXECUTIVE SUMMARY
5. INTRODUCTION
5.1. Chapter Overview
5.2. Concept of an Antibody
5.3. Structure of an Antibody
5.4. Antibody Isotypes
5.5. Mechanism of Action of Antibodies
5.6. Types of Antibodies
5.6.1. Monoclonal Antibodies
5.6.2. Bispecific Antibodies
5.6.3. Polyclonal Antibodies
5.7. Overview of Contract Manufacturing
5.8. Need for Outsourcing in the Biopharmaceutical Industry
5.9. Advantages of Outsourcing Manufacturing Services